These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1527785)

  • 1. Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazines.
    Bonnet PA; Michel A; Laurent F; Sablayrolles C; Rechencq E; Mani JC; Boucard M; Chapat JP
    J Med Chem; 1992 Sep; 35(18):3353-8. PubMed ID: 1527785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series].
    Bonnet PA; Vitse O; Bénezech V; Subra G; Fabréguettes JR; Zanik L; Laurent F; Michel A; Bompart J; Chapat JP
    Ann Pharm Fr; 1998; 56(4):155-9. PubMed ID: 9770008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New imidazo(1,2-a)pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities.
    Vitse O; Laurent F; Pocock TM; Bénézech V; Zanik L; Elliott KR; Subra G; Portet K; Bompart J; Chapat JP; Small RC; Michel A; Bonnet PA
    Bioorg Med Chem; 1999 Jun; 7(6):1059-65. PubMed ID: 10428374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activities of imidazo[1,2-alpha]pyrazine derivatives.
    Michel A; Laurent F; Chapat JP; Boucard M; Bonnet PA
    Arzneimittelforschung; 1995 Dec; 45(12):1288-93. PubMed ID: 8595086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New bronchodilators. 1. 1,5-Substituted 1H-imidazo[4,5-c]quinolin-4(5H)-ones.
    Suzuki F; Kuroda T; Nakasato Y; Manabe H; Ohmori K; Kitamura S; Ichikawa S; Ohno T
    J Med Chem; 1992 Oct; 35(22):4045-53. PubMed ID: 1331454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bronchodilators. II. 3H-imidazo[4,5-c]quinolin-4(5H)-ones.
    Suzuki F; Kuroda T; Hayashi H; Nakasato Y; Manabe H; Ohmori K; Kitamura S
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3245-52. PubMed ID: 1294327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones.
    Suzuki F; Kuroda T; Kawakita T; Manabe H; Kitamura S; Ohmori K; Ichimura M; Kase H; Ichikawa S
    J Med Chem; 1992 Dec; 35(26):4866-74. PubMed ID: 1479586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Substituted 5-chloro-1,3-dihydro-2H-imidazo(4,5-b)pyrazin-2-ones with hypotensive activity.
    Jones JH; Holtz WJ; Cragoe EJ
    J Med Chem; 1973 May; 16(5):537-42. PubMed ID: 4352334
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of imidazo[1,2-a]pyrazine derivatives with uterine-relaxing, antibronchospastic, and cardiac-stimulating properties.
    Sablayrolles C; Cros GH; Milhavet JC; Rechenq E; Chapat JP; Boucard M; Serrano JJ; McNeill JH
    J Med Chem; 1984 Feb; 27(2):206-12. PubMed ID: 6319701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of some 10-substituted 2,3-dihydroimidazo[2,1-b]quinazolin-5(10H)-ones, a new class of bronchodilators.
    Hardtmann GE; Koletar G; Pfister OR; Gogerty JH; Iorio LC
    J Med Chem; 1975 May; 18(5):447-53. PubMed ID: 239232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiulcer agents. 3. Structure-activity-toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine.
    Kaminski JJ; Perkins DG; Frantz JD; Solomon DM; Elliott AJ; Chiu PJ; Long JF
    J Med Chem; 1987 Nov; 30(11):2047-51. PubMed ID: 3669012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.
    Mukaiyama H; Nishimura T; Kobayashi S; Ozawa T; Kamada N; Komatsu Y; Kikuchi S; Oonota H; Kusama H
    Bioorg Med Chem; 2007 Jan; 15(2):868-85. PubMed ID: 17095233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bronchodilators: synthesis, transamination reactions, and pharmacology of a series of pyrazino[2,3-c][1,2,6]thiadiazine 2, 2-dioxides.
    Campillo N; García C; Goya P; Alkorta I; Páez JA
    J Med Chem; 2000 Nov; 43(22):4219-27. PubMed ID: 11063618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic effects of imidazo[1,2-a]pyrazine derivatives in the human Dami cell line.
    Zurbonsen K; Michel A; Bonnet PA; Gannoun-Zaki L; Mathieu MN; Chevillard C
    Eur J Pharmacol; 1997 Feb; 320(2-3):215-21. PubMed ID: 9059857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator activity of theophylline derivatives substituted at the 7-position.
    Corsano S; Scapicchi R; Strappaghetti G
    Arch Pharm (Weinheim); 1994 Oct; 327(10):631-5. PubMed ID: 7826198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligands.
    Hartz RA; Gilligan PJ; Nanda KK; Tebben AJ; Fitzgerald LW; Miller K
    Bioorg Med Chem Lett; 2002 Feb; 12(3):291-4. PubMed ID: 11814780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase.
    Zhao F; Zhang J; Zhang L; Hao Y; Shi C; Xia G; Yu J; Liu Y
    Bioorg Med Chem; 2016 Sep; 24(18):4281-4290. PubMed ID: 27448775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclic 3',5'-adenosine monophosphate phosphodiesterase by substituted imidazopyrazines.
    Mandel LR
    Biochem Pharmacol; 1971 Dec; 20(12):3413-21. PubMed ID: 4332205
    [No Abstract]   [Full Text] [Related]  

  • 20. 1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors.
    Mulvihill MJ; Ji QS; Werner D; Beck P; Cesario C; Cooke A; Cox M; Crew A; Dong H; Feng L; Foreman KW; Mak G; Nigro A; O'Connor M; Saroglou L; Stolz KM; Sujka I; Volk B; Weng Q; Wilkes R
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1091-7. PubMed ID: 17127062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.